(Q39843596)

15 September 2017

title

Application of interleukin-12 expressing dendritic cells for the treatment of animal model of leukemia (English)

1 reference

15 September 2017

0 references

1 reference

Bor-Yu Tsai

1

1 reference

15 September 2017

Yu-Li Lin

series ordinal

2

1 reference

15 September 2017

Bor-Luen Chiang

series ordinal

3

1 reference

15 September 2017

publication date

2 June 2009

1 reference

Experimental Biology and Medicine

15 September 2017

published in

1 reference

15 September 2017

volume

234

1 reference

15 September 2017

issue

8

1 reference

15 September 2017

page(s)

952-960

1 reference

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Dendritic cells modified with 6Ckine/IFNgamma fusion gene induce specific cytotoxic T lymphocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Interleukin-12: biological properties and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN alpha on visible B16 mouse melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Determination of subcutaneous tumor size in athymic (nude) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Recombinant interleukin-12 and interleukin-18 antitumor therapy in a guinea-pig hepatoma cell implant model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0805-RM-165

21 January 2018

Identifiers

DOI

10.3181/0805-RM-165

1 reference

15 September 2017

1 reference